Tectonic Therapeutic (TECX) Interest Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Interest Expenses data on file, last reported at $28.7 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 18895.36% year-over-year to $28.7 million in Q1 2026; TTM through Mar 2026 was $28.7 million, a 18895.36% increase from a year earlier, with the FY2025 full-year figure at $188.9 million, up 11.0% from the prior year.
• Interest Expenses for Q1 2026 stood at $28.7 million, up from $12000.0 in the prior quarter.
• Over the last five years, Interest Expenses for TECX reached as high as $33.5 million in Q3 2024 and fell as low as $12000.0 in Q4 2025.
• Historically, Interest Expenses has averaged $5.0 million across 5 years, with a median of $994000.0 in 2023.
• Across the five-year window, Interest Expenses sank 99.83% in 2025 and surged 18895.36% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $528000.0 in 2022, then tumbled by 93.56% to $34000.0 in 2023, then tumbled by 35.29% to $22000.0 in 2024, then sank by 45.45% to $12000.0 in 2025, then jumped by 238925.0% to $28.7 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $28.7 million in Q1 2026, $12000.0 in Q4 2025, and $5.3 million in Q3 2025.